StudyFinder
MT2013-06C : Treatment of graft Failure after HSCT
Status: Recruiting
The primary purpose of this study is to record outcomes and patient characteristics in the Masonic Cancer Center and BMT databases for patients undergoing a second transplant using a haploidentical donor, an unrelated donor or umbilical cord blood. The data will be analyzed for transplant “milestones” such as time to blood count recovery (engraftment) and how patients are doing at 3 months and 6 months after the transplant. Participation in this study will not alter treatment or medical care. All information for this study will be collected from medical records.
Sex: Male or Female
Age Group: Not specified
Inclusion Criteria:
• patients with primary or secondary HSCT graft failure
• see link to clinicaltrials.gov for complete Inclusion and Exclusion criteria
Exclusion Criteria:
• uncontrolled infection at the time of transplant
• patients with Fanconi Anemia or other DNA breakage syndromes
Keywords:
Clinics and Surgery Center (CSC), Failure, Hematopoietic Stem Cell Transplantation, HSCT
Study Contact: Timothy Krepski - tkrepsk1@fairview.org
Principal Investigator: Troy Lund
IRB Number: 1404M49341
See this study on ClinicalTrials.gov